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1 Both authors contributed equally to the perpetratiFocused attention typically enhances neural nociceptive responses, reﬂected electroencephalographically
as increased amplitude of pain-evoked event-related potentials (ERPs). Additionally, pain-evoked ERPs
are attenuated by hypertension and baroreceptor activity, through as yet unclear mechanisms. There is
indirect evidence that these two effects may interact, suggesting that baroreceptor-related modulation
of nociception is more than a low-level gating phenomenon. To address this hypothesis, we explored
in a group of healthy participants the combined effects of cue-induced expectancy and baroreceptor
activity on the amplitude of pain-evoked ERPs. Brief nociceptive skin stimuli were delivered during a sim-
ple visual task; half were preceded by a visual forewarning cue, and half were unpredictable. Nociceptive
stimuli were timed to coincide either with systole (maximum activation of cardiac baroreceptors) or with
diastole (minimum baroreceptor activation). We observed a strong interaction between expectancy and
cardiac timing for the amplitude of the P2 ERP component; no effects were observed for the N2 compo-
nent. Cued stimuli were associated with larger P2 amplitude, but this effect was abolished for stimuli pre-
sented during baroreceptor activation. No cardiac timing effect was observed for un-cued stimuli. Taken
together, these ﬁndings suggest a close integration of cognitive–affective aspects of expectancy and baro-
receptor inﬂuences on pain, and as such may cast further light on mechanisms underlying mental and
physiological contributions to clinical pain.
 2010 International Association for the Study of Pain. Published by Elsevier B.V.
Open access under CC BY license. 1. Introduction stimuli can be attenuated by discharge of cardiac and arterialPain expectation mobilises attentional resources toward rele-
vant external and internal stimuli facilitating adaptive behavioral
and physiological responses. Attention modulates both subjective
experience [5] and neural correlates [42] of pain, directing atten-
tion toward pain, relative to non direction or distraction, and in-
creases pain-evoked ERP amplitudes [8,34,50,75,76]. Similarly,
both hypnotic suggestion and expectations about pain modulate
electroencephalographic [17] and functional imaging indices of
nociceptive processing [41,68]. Thus the neural responses that
track subjective pain [14,18,43] do not simply reproduce energy
delivered by nociceptive stimuli, but are shaped by cognitive and
affective processes [41,55].
Nociceptive processing is also inﬂuenced by visceral state.
Even within the short timeframe of the cardiac cycle, nociceptivetudy of Pain. Published by Elsevie
s Centre (CISC), Brighton and
ighton, East Sussex, BN1 9RR,
. Gray), lminati@ieee.org (L.
on of this manuscript.baroreceptors, activated naturally at systole by phasic ejection of
blood from the heart [3,13,35]. Experimentally, increasing barore-
ceptor discharge through artiﬁcial stimulation (phase related exter-
nal suction, PRES, over the neck in the carotid region [23,27,59])
typically reduces subjective pain ratings [4,11,22,45,54], without
necessarily affecting pain detection thresholds [22,45]. Barorecep-
tor activity similarly modulates neural signatures of pain process-
ing: PRES, coupled to baroreceptor activation occurring naturally
during cardiac systole, engenders a negative shift in pain-evoked
ERPs [60], and timing nociceptive stimuli in relation to natural sys-
tolic baroreceptor discharge inﬂuences the amplitude of the N2 and
P2 components of pain-evoked ERPs [4,11,26,54]. Baroreceptor dis-
charge also inﬂuences skeletomotor [59] and autonomic reﬂexes to
nociceptive stimulation, inhibiting activity in sympathetic nerves
supplying skeletal muscles (muscle sympathetic nerve activity;
MSNA) [19], an effect associated with attenuated blood pressure re-
sponses to pain [20,21,39,72]. Thus nociceptive processing can be
modulated by baroreceptor activation, as evidenced by alterations
in subjective reports, pain-evoked potential amplitudes and auto-
nomic reactions.
Inﬂuential theories suggest a central role of visceral afferent
information in emotion and motivation [15,16,58], yet it is unclearr B.V. Open access under CC BY license. 
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stasis or low-level sensory gating. Nociceptive processing provides
a unique window to explore how baroreceptor activity might inter-
act with cognitive and motivational functions. Of direct relevance
is the observation by Donadio and co-workers that infrequent noci-
ceptive stimuli presented during baroreceptor discharge have the
greatest selective impact on autonomic reactions (enhancing
MSNA inhibition without altering sympathetic skin responses).
Moreover, MSNA inhibition rapidly habituates if stimuli are re-
peated over ﬁve consecutive cardiac cycles [20]. One interpretation
is that the initial nociceptive stimulus carries attentional salience,
amplifying baroreceptor inhibition of MSNA, but subsequent stim-
uli lose salience and have diminished baroreceptor-related effects.
Alternatively, the effect may emerge from refractory characteris-
tics of homoeostatic neurons that speciﬁcally fatigue MSNA inhibi-
tion across consecutive cardiac cycles.
The current study, extending earlier neuroimaging work [39],
was motivated to examine the interaction between attentional sal-
ience and phasic visceral effects in nociception. We modulated
expectancy by embedding nociceptive stimuli within a visual task,
to dissect attentional and baroreceptor inﬂuences. We hypothe-
sized that if expectancy and attention, rather than physiological
habituation, modulate the baroreceptor gating of pain responses
[20], then the baroreceptor inﬂuence on the pain-evoked ERPs
would be different between expected and unexpected pain, sug-
gesting that attentional effects on central nociception are mecha-
nistically dependent on visceral state.2. Methods
2.1. Participants and recording procedure
Eleven adults (age 28 ± 9.8 years) participated in the experi-
ment after providing written informed consent. To avoid recog-
nized gender differences in nociceptive processing [7,31] we
restricted our sample to female participants. All participants were
medication free at the time of testing and reported no history of
psychiatric or neurologic disorders. The study was approved by
the Brighton and Sussex Medical School (BSMS) research gover-
nance and ethics committee. All recordings were performed in a
psychophysiology laboratory, with the participant comfortably
seated in a dimly-lit, quiet room while the experimenter remained
nearby.
2.2. Physiological and EEG recordings
Beat-to-beat blood pressure was recorded through a ﬁnger cuff
applied on the left hand using the volume-clamp method of Peñáz
as implemented by the Finometer device (Finapres Medical Sys-
tems BV, Arnhem, The Netherlands). Three lead ECG recordings
were made with Ag–AgCl electrodes positioned according to Ein-
thoven’s triangle, standard lead I conﬁguration, using an isolated
pre-ampliﬁer (model 1902, CED Ltd., Cambridge, UK). The electro-
cardiogram (ECG) and blood pressure signals were digitized
through a ‘power1401’ data acquisition device (CED) and recorded
on a PC running the Spike2 version 7 software.
The electroencephalogram (EEG) was recorded through 19 elec-
trodes positioned according to the 10/20 system and held in place
by a lycra cap (Electro-Cap Inc., Eaton OH, USA), using a Mindset
MS-24 EEG system (Nolan Computer Systems, Inc., Fort Morgan
CO, USA) electrically isolated from all other equipment. After
band-pass ﬁltering in the 0.1–30 Hz range, signals were sampled
at 512 Hz. Recordings were performed relative to a linked-ears ref-
erence, and individual electrode impedances were kept below
5 kX.2.3. Experimental task
Participants performed a passive viewing task, in which four
white visual shapes (square, circle, rhombus or triangle) were dis-
played on a black background for 300 ms by means of a CRT
screen positioned at 1 m distance. They were initially shown each
stimulus shape and the experimenter indicated which one, ran-
domly chosen for each session, would be the ‘target’ and would
therefore always be followed by a nociceptive electrical skin stim-
ulus (see Fig. 1A–C). Targets accounted for 25% of visual stimuli.
Nociceptive stimuli were timed to either coincide with the ECG
R-wave or to be delivered 300 ms after it. The R-wave corresponds
to the end of cardiac diastole, and therefore to relative barorecep-
tor inactivity. On the contrary, 300 ms after the R-wave corre-
sponds approximately to the systole, when baroreceptor ﬁring is
maximal. In other words, in order to perform this study we did
not measure the latency of baroreceptor activation with respect
to the R-wave, but we assumed these timings a priori, on the
basis of the convergent ﬁndings reported in existing literature
[25–28,39,53].Throughout this paper, stimuli presented during
the ECG R-wave are termed ‘‘baroreceptor silent stimuli” whereas
stimuli presented 300 ms following the ECG R-wave are termed
‘‘baroreceptor active stimuli”. The timing of the electrical stimuli
was controlled by a real-time script running on the CED-
power1401 unit, identifying the QRS complex with sub-millisec-
ond temporal accuracy. Participants were informed that, in
addition to the nociceptive stimuli cued by the visual target, un-
cued stimuli would also be presented at unpredictable points
throughout the task.
A complicating factor is the possibility of expectancy-induced
cardiovascular responses, since increased blood pressure during
pain anticipation may attenuate pain processing [24,48,62]. Conse-
quently, the average time between the cue and the electrical stim-
ulus was kept brief (3.1 ± 0.3 s), corresponding to a jitter of about
10% which included the variable delay due to cardiac synchroniza-
tion. Additionally, jittering the cue-to-nociceptive-stimuli interval
ensured that the effect of cue-induced expectancy on the ERPs
could not be confounded by synchronization of EEG rhythms
potentially induced by the visual stimuli. Considering all stimuli
(visual and electrical) together, the average inter-stimulus time
was 2.6 ± 0.5 s; separately, visual stimuli occurred every
3.9 ± 1.7 s, and nociceptive electrical stimuli every 7.4 ± 4.5 s. We
speciﬁcally ensured nociceptive stimuli were never delivered dur-
ing consecutive cardiac cycles to minimise the possible refractory
attenuation of baroreceptor inﬂuences. The corresponding distri-
butions are shown in Fig. 1D.
Participants completed the task in four blocks of about 380 s
each, with a pause of approximately 140 s between blocks. Painful-
ness ratings for the electrical-skin stimuli were verbally collected
after each block on a 1 (barely identiﬁable as pain) to 10 (imagi-
nary worst possible pain) scale, and averaged across blocks. The
overall task duration was approximately 30 min. In total, 200 noci-
ceptive electrical-skin stimuli were delivered, evenly balanced be-
tween the baroreceptors silent and active conditions, and between
the cued and un-cued conditions.
2.4. Electrical-skin stimuli
Two standard EEG electrodes (Ag–AgCl, 5 mm radius circular
cup ﬁlled with Ten20 conductive paste) separated by approxi-
mately 1 cm were attached to the right ventral wrist. Electrical-
skin stimuli were delivered by means of a constant-current
stimulator (DS7A, Digitimer Ltd., Glenwyn Garden City, UK), and
consisted of a single square-wave pulse with 2 ms width and max-
imum voltage 400 V. Before starting the experimental task, stimu-
lus intensity was determined on an individual by individual basis.
Fig. 1. Task design and stimulus frequency. (A) Participants observed four visual stimuli, one of which consistently cued subsequent nociceptive stimuli; in this illustration,
the circle acts as the pain cue. (B) Cued and non-cued nociceptive stimuli were timed to coincide with baroreceptor active (300 ms after the ECG R-wave) or baroreceptor
silent periods (during the ECG R-wave). (C) Cardiac-paced nociceptive stimuli were either explicitly cued (cues represented here as gray rectangles) or presented without a
warning cue. (D) Histograms of the distribution of inter-stimulus intervals. Left: bin centers: 1.74–3.92 s, bin width 1551 ms. Right: bin centers: 2.50–29.82 s, bin width
1608 ms).
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was incrementally increased in 2 mA steps until participants re-
ported perceiving the stimulus as ‘painful’ for three presentations
in row. Stimuli were then maintained at these levels during the fol-
lowing experimental task. Across participants, the stimulus inten-
sity was 17 ± 8 mA.
2.5. Data analysis
All EEG channels were re-referenced to the mean of all elec-
trodes, and then epoched in the 100 ms to 800 ms peristimulus
range. Baseline removal was performed using the 100 ms pre-stim-
ulus level. On the basis of the grand-average traces of all partici-pants and electrodes, the measurement windows were set to
200 ± 40 and 400 ± 40 ms for the N2 and P2 components, respec-
tively. Investigating evoked-potentials within a cardiac-paced de-
sign raises the potential for confounding effects due to
contamination of the EEG signal by the ballistocardiogram [1], a
possibility which no study within this ﬁeld has to date explicitly
considered. Consequently, we speciﬁcally measured and removed
the ECG-related artefact from our ERP traces. The artefact was
determined by averaging each EEG channel over cardiac cycles
during which no stimuli were delivered. As in the EPR analysis,
baseline removal subtracted consisted of subtracting the mean
100 ms pre-stimulus activity, producing a measure of ECG induced
artefacts in each EEG channel, separately for baroreceptor silent
Fig. 2. Grand-average waveforms of the event-related potentials evoked by nociceptive stimulation and corresponding scalp distributions. (A) Grand average (across all
participants and the C3, Cz and C4 sites) after removal of the ECG artefact. (B) Grand average prior to artefact removal (left) and corresponding ECG artefact (right). (C) Scalp
distribution of the N2 component. (D) Scalp distribution of the P2 component.
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statistical analysis using the N2 and P2 time-windows, the result-
ing averaged artefact was subtracted from the evoked-potentials
recorded for the electrical stimuli.
The arterial pressure signal was low-pass ﬁltered at 10 Hz and
pre-processed with a peak-picking algorithm which yielded mean
arterial pressure (MAP), systolic and diastolic values for each beat.
The ECG signal was low-pass ﬁltered at 50 Hz and pre-processed
with an algorithm identifying each R-wave and yielding a heart-
rate value for each beat. For all physiological measures, polynomial
detrending was performed over the entire session using a third-de-
gree polynomial.
In order to evaluate the physiological effect of nociceptive elec-
trical-skin stimuli, changes in MAP and heart rate were calculated
for the three post-stimulus beats with respect to the average of the
three beats preceding each stimulus. We also measured physiolog-
ical changes immediately preceding the nociceptive stimulus elic-
ited by the visual warning cue, by considering the difference
between the two beats preceding the electrical stimulus and the
3.5 to 4.5 s pre-stimulus period; this temporal window always
preceded presentation of the visual warning cue. To determine
whether this difference was statistically signiﬁcant, we compared
it with that observed for un-cued pain stimuli by means of two-
tailed paired t-tests.
Statistical analysis of the peripheral physiology and ERP data
was performed by ANOVAs, using within-subject factors for car-
diac timing (baroreceptors silent or active) and expectancy (cued
or un-cued pain). For the ERP analysis, data from the C3, Cz, and
C4 sites, at which the N2/P2 component amplitude was the largest
(see Section 3), were pooled together introducing an additional fac-
tor for site. Further, blood pressure and heart rate measurementsas well as painfulness ratings were entered in the analyses as be-
tween-subject covariates. Where appropriate, results were subject
to Greenhouse–Geisser correction for violation of the sphericity
assumption. Further, Bonferroni’s correction was applied to ac-
count for multiple comparisons.3. Results
3.1. Peripheral physiology and pain ratings
Overall, participants rated the painfulness of the stimuli at
4.1 ± 1.0 (scale 1–10). Averaging over the whole experimental
session, the heart rate (HR) was 73 ± 12 bpm, and the systolic,
diastolic and mean arterial (MAP) blood pressures were respec-
tively, 127 ± 26, 73 ± 19, 94 ± 24 mm Hg. There was no correlation
between painfulness ratings and baseline MAP values (p = 0.8).
The results of the beat-to-beat analyses of blood pressure and heart
rate changes following nociceptive stimulation are given in Table 1.
After correcting formultiple comparisons (a = 0.004), therewere no
signiﬁcantmain effects of expectancy or timing, andno interactions.
As regards to the physiological correlates of expectancy preceding
pain delivery, there were no effects on MAP (0.09 ± 0.26 Dmm Hg
vs. 0.09 ± 0.24 Dmm Hg, t(11) = 2.1, p = 0.06) and HR (0.10 ± 0.68
Dbpm vs. 0.13 ± 0.53 Dbpm, t(11) = 0.1, p = 0.9).
3.2. Effect of physiological changes and perceived painfulness on ERP
components
Despite the absence of statistically signiﬁcant effects of the
warning cue on MAP and HR (see above), we examined whether
M.A. Gray et al. / PAIN

151 (2010) 853–861 857the physiological state immediately preceding nociceptive stimu-
lation, indexed by MAP and HR, modulated the effects of expec-
tancy and cardiac timing on the N2 and P2 component amplitudes.
Considering the N2 component, the amplitude of the pre-stim-
ulus MAP change, entered in the analysis as between-subjects
covariate, did not interact with expectancy (p = 0.9) or cardiac tim-
ing (p = 0.9). Likewise, we observed no interaction of HR change
with expectancy (p = 0.7) or with cardiac timing (p = 0.7). Similarly,
when considering the P2 component, there was no signiﬁcant
interaction of MAP change with expectancy (p = 1) or cardiac tim-
ing (p = 1). Again, we also observed no interaction of HR change
with expectancy (p = 0.7) or with cardiac timing (p = 0.7). These
covariates were therefore removed from subsequent analyses.
In addition to physiological changes, we also examined associa-
tions between painfulness ratings and the N2 and P2 amplitudes.
For the N2 component, pain ratings did not interact with expec-
tancy (p = 0.2) or cardiac timing (p = 0.3). Likewise for the P2, pain-
fulness ratings did not interact with expectancy (p = 0.9) or cardiac
timing (p = 0.4). This covariate was therefore removed from subse-
quent ERP analyses.
3.3. Factorial analysis of ERP components
The amplitude of the ECG artefact was minimal compared with
that of the evoked responses and the observed artefact decayedTable 1
Effect of expectancy and cardiac timing on physiological measures. ‘‘Silent” and
‘‘Active” refer to baroreceptor status. Values are given as mean ± SD. In order to
account for multiple comparisons, Bonferroni’s correction indicates a = 0.004.
Stim Beat 1 2 3
Cardiac cycles post-stimulus
Systolic pressure/DmmHg
Cued pain, silent 0.2 ± 0.4 0.1 ± 0.9 0 ± 1.1 0.1 ± 1.2
Cued pain, active 0.3 ± 0.7 0.7 ± 0.8 0.3 ± 1.4 0.3 ± 1.8
Un-cued pain, silent 0.2 ± 0.6 0.2 ± 1 0.4 ± 1.1 0.5 ± 1.2
Un-cued pain, active 0.3 ± 0.8 0.5 ± 0.9 0.4 ± 0.6 0.3 ± 1
Expectancy P = 0.3 P = 0.9 P = 0.6 P = 0.7
Timing P = 0.2 P = 0.1 P = 0.5 P = 0.9
Timing  expectancy P = 0.01 P = 0.4 P = 0.5 P = 0.4
Diastolic pressure/DmmHg
Cued pain, Silent 0.1 ± 0.4 0.2 ± 0.6 0.2 ± 0.9 0.1 ± 0.9
Cued pain, Active 0.1 ± 0.4 0.4 ± 0.8 0.5 ± 1.0 0.2 ± 1.1
Un-cued pain, Silent 0.1 ± 0.4 0.4 ± 0.5 0.4 ± 0.7 0.4 ± 0.6
Un-cued pain, Active 0.2 ± 0.2 0.3 ± 0.3 0.3 ± 0.5 0 ± 0.4
Expectancy P = 0.7 P = 0.8 P = 0.9 P = 0.6
Timing P = 0.6 P = 0.9 P = 0.8 P = 0.9
Timing  Expectancy P = 0.4 P = 0.6 P = 0.4 P = 0.2
Heart rate/Dbpm
Cued pain, Silent 0.7 ± 1.1 0.2 ± 0.9 0.2 ± 1.2 0.3 ± 1.1
Cued pain, Active 0.3 ± 1.0 0.7 ± 0.9 0 ± 1.2 0.2 ± 1.5
Un-cued pain, Silent 0.3 ± 0.9 0.2 ± 1.2 0.4 ± 1.2 0.6 ± 1.3
Un-cued pain, Active 0.4 ± 0.9 0.5 ± 1 0.1 ± 1.3 0.2 ± 1.6
Expectancy P = 0.7 P = 0.4 P = 0.5 P = 0.7
Timing P = 0.6 P = 0.02 P = 0.4 P = 0.5
Timing  Expectancy P = 0.3 P = 0.6 P = 0.9 P = 0.7
Table 2
ERP component amplitudes. Values are given in microvolt (lV), as mean ± SD.
Cued stimuli
C3 Cz C4
N2 component
Baroreceptor Silent 5.6 ± 3.8 7.5 ± 4.7 4
Baroreceptor Active 6.0 ± 4.3 7.9 ± 5.2 4
P2 component
Baroreceptor Silent 4.0 ± 2.2 4.8 ± 2.7 3
Baroreceptor Active 3.4 ± 1.9 4.0 ± 2.3 2within 100 ms after the R-wave, therefore preceding the temporal
windows considered in this study (Fig. 2A–B). Statistical analysis
conﬁrmed that there was no signiﬁcant artefact-related bias nei-
ther in the N2 window (p = 0.5) nor in the P2 window (p = 0.1).
As shown in Fig. 2C–D, the N2 and P2 components had a central
distribution over the scalp surface, with maximum amplitude at
the C3, Cz and C4 sites which were considered for all ERP measure-
ments in this study.
As regards to the effects of the experimental conditions, for the
N2 component there were no main effects of expectancy (p = 0.8)
and cardiac timing (p = 0.7) and no interaction (p = 0.4). The corre-
sponding potentials are given in Table 2, and scatter plots and sig-
niﬁcance maps are shown in Fig. 3A–C.
By contrast, as represented in Fig. 3D, for the P2 component a
signiﬁcant expectancy by cardiac timing interaction was observed
(F(1,11) = 12.1, p = 0.005, g2p ¼ 0:52), without main effects of
expectancy (p = 0.1) or cardiac timing (p = 0.4). We performed post
hoc ANOVAs exploring the effect of expectancy on the P2 ampli-
tude separately for stimuli delivered while the baroreceptors were
silent, and while baroreceptors were active When considering only
baroreceptor silent stimuli, we observed a signiﬁcant effect of
expectancy (F(1,11) = 13.2, p = 0.004, g2p ¼ 0:55), (see Fig. 3F) with
larger amplitude for cued stimuli; there was no signiﬁcant interac-
tion with side (p = 0.8). The corresponding ANOVA for stimuli pre-
sented while the baroreceptors were active did not reveal an effect
of expectancy (p = 0.3), and again no signiﬁcant lateralization
(p = 0.4) (Fig. 3F).
Additional post hoc ANOVAs were performed to explore the ef-
fect of cardiac timing separately for cued and un-cued stimuli.
These revealed that there was a cardiac timing effect for cued
(F(1,11) = 7.2, p = 0.02, g2p ¼ 0:40) but not for un-cued stimuli
(p = 0.4). The observed effect consisted of an attenuation of the
P2 amplitude following cued stimuli presented while the barore-
ceptors were active; the effect was most strongly signiﬁcant over
the C3, Cz, and C4 sites and was not signiﬁcantly lateralized
(p = 0.3, Fig. 3E).
For consistency with previous work, we also examined the N2-
P2 difference, for which there were no main effects of expectancy
(p = 0.3) or cardiac timing (p = 0.8) and no interaction (p = 0.3).
4. Discussion
Our principal ﬁnding is an expectancy by cardiac timing inter-
action on the amplitude of the pain-evoked P2 component. This
can be interpreted from two complementary perspectives, through
post hoc tests performed either separately for cued and un-cued
stimuli, or separately for stimuli presented with active or silent
baroreceptors. We found that cue-associated expectation of pain
increased the P2 amplitude for stimuli presented without the
simultaneous inﬂuence of baroreceptor discharge; this effect was
abolished when stimuli were presented coincident with barorecep-
tor discharge. Further, baroreceptor discharge attenuated the P2
amplitude in a statistically signiﬁcant manner only for cued stim-Un-cued stimuli
C3 Cz C4
.5 ± 3.5 5.6 ± 4.3 7.7 ± 5.1 4.6 ± 3.7
.5 ± 3.7 4.3 ± 4.0 7.5 ± 4.9 4.3 ± 3.6
.1 ± 2.1 3.4 ± 2.0 4.1 ± 2.5 2.3 ± 2.1
.5 ± 1.9 3.7 ± 2.1 4.3 ± 2.5 2.6 ± 2.2
Fig. 3. Scatter plots and scalp distributions of statistical signiﬁcance. For the N2 component, no effects of cardiac timing are observed either on the scatterplot (A) or on the
scalp maps of cardiac timing (B) or expectancy effects (C). By contrast, P2 amplitude reveals a signiﬁcant timing by expectancy interaction (D). Post hoc comparisons
exploring cardiac timing (E) reveal increased P2 amplitude when baroreceptors were silent only when stimuli are presented after a cue. There is no cardiac timing effect for
un-cued stimuli. The complementary post hoc tests exploring expectancy (F) demonstrate increased P2 amplitude for cued stimuli only when these are presented while the
baroreceptors are silent. There is no expectancy effect for stimuli presented during baroreceptor activation.
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were attending to the visual stimuli), a trend in the opposite direc-
tion was observed, but this was clearly not signiﬁcant (p = 0.4).
These results raise intriguing possibilities concerning the mecha-
nisms by which expectancy and phasic visceral signals interact in
their inﬂuence on pain-evoked potentials. Neither the visual cues
indicating imminent nociceptive stimulation nor the stimuli them-
selves were embodied in signiﬁcant changes of blood pressure or
heart rate, and therefore did not confound the central expec-
tancy-related inﬂuences on nociceptive processing. Reassuringly,
we found no signiﬁcant effect of ECG contamination on the ERP
traces, enabling us to rule out a potential direct confounding effect
related to the ballistocardiogram.
We manipulated pain expectancy by embedding nociceptive
stimuli within a visual task including an explicit cue predicting
nociceptive stimulation. Cue presentation alters attentional focus,
shifting it from the visual stimuli towards imminent painful stim-
ulation. Previous research demonstrates that directed attention in-
creases experienced pain, whereas distraction reduces it [5,63,64],an effect which is also manifest in increased amplitudes of pain-
evoked potentials [49–51,55]. Our results are partially in line with
these studies. Without the simultaneous inﬂuence of baroreceptor
activation, cue-induced expectation of pain was associated with in-
creased P2 amplitude, in agreement with the interpretation based
on attentional focus. Nevertheless, this effect was absent for stim-
uli presented during baroreceptor activation. We hypothesize that
this is because baroreceptor ﬁring disrupts the attentional modula-
tion; none of the previous studies on attentional modulation ex-
plored this effect, as stimuli were not timed to the cardiac cycle.
A few limitations should be mentioned: ﬁrstly restricting our sam-
ple to females restricts the generalizability of ﬁndings, and future
research could control for effects of menstrual phase on nocicep-
tion. Secondly, while the time-course of our evoked potentials is
consistent with a-delta pain-evoked potentials, electrical-skin
stimuli delivered to the ventral wrist may also activate a-beta so-
mato-sensory ﬁbers. More selective a-delta stimulation by laser
stimulation of the dorsal hand would reduce the potential for
interference by somatosensory evoked potentials. Thirdly, we
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spond to minimal and maximal baroreceptor activation; even
though this assumption appears well-supported by the available
literature, we did not conﬁrm its validity, and it is likely that unac-
counted inter-individual differences were present to some extent.
Additionally, in this study an analysis on the QT intervals was
not performed, calling for further investigation in combination
with more comprehensive autonomic response monitoring.
Fourthly, due to time limitations we did not perform a control
examination with non-nociceptive stimuli. As a consequence, even
though the observed N2/P2 complex is speciﬁc to nociceptive stim-
uli, we cannot exclude that analogous effects could be present on
the responses elicited by weaker, non-nociceptive stimuli.
In the present study, pain delivery during baroreceptor activity
was associated with attenuated P2 amplitude only for stimuli pre-
ceded by the warning cue. This partially agrees with previous ﬁnd-
ings indicating that the pain-evoked potentials, namely the N2, P2
or N2-P2 peak-to-peak amplitudes, are reduced during barorecep-
tor discharge [4,11,26,54]. In our case, this effect was only ob-
served for cued stimuli. We speculate that this selective effect is
related to the different subjective experiences of pain for cued
and un-cued stimuli, given that the P2 is known to correlate with
subjective ratings of pain intensity; however, we cannot explore
this hypothesis, because we did not vary pain intensity or measure
subjective ratings of individual pain stimuli [4,11,12,22,29,45,54].
Our results are consistent with a conceptual model based on
two ‘‘gating” or ‘‘modulation” processes, wherein expectation of
pain acts as a context depending on which baroreceptor activity
may or may not attenuate central neural responses to pain
(Fig. 4). These results suggest that cognitive attentional inﬂuences
on pain may be gated by phasic afferent signals from the heart and
vasculature. This extends the existing literature in which barore-
ceptor gating of sensory processes is restricted to brainstem nuclei,
without interactions with cortico-limbic processing. The absence
of a cardiac timing effect when attention was directed to visual
stimuli suggests that cognitive processes contribute to the inﬂu-
ence of baroreceptor activation on nociception. One interpretation
is that the ‘‘analgesic” effects of baroreceptor activation obligato-
rily require salient or attentionally-focused pain. This is consistent
with Donadio’s [20] ﬁndings, in that the ﬁrst stimulus in each trainFig. 4. Conceptual model of the interaction between attentional and baroreceptor-
related effects on the amplitude of the nociceptive P2 ERP component. There are
two ‘‘gating” or ‘‘modulation” mechanisms. One (A) represents the effect that
attentional focus has on the P2, conditional to the state of another mechanism (B),
which represents baroreceptor activation. When baroreceptors are quiet, ‘‘gate” B is
open and the attentional effect can reach A, and thereby modulate the P2
amplitude. However, when the baroreceptors are active, ‘‘gate” B blocks the effect
of attention, and no cueing-related effect is observed on the P2. Baroreceptor
activity does not directly inﬂuence the P2 amplitude, it only has an opportunity to
do so by gating the attentional signal through B.of nociceptive stimuli may have been more attentionally salient
than the predictable and regular subsequent ones, especially given
that a long inter-stimulus interval (i.e., effectively 60 s) was used.
In our study, the period of expectancy and the overall inter-stimu-
lus intervals were kept brief, nevertheless, the explicit cues which
always predicted painful stimulation likely increased salience and
attention for the cued stimuli. Taken together, these two studies
therefore suggest that attention may be more relevant to barore-
ceptor mediated-attenuation of nociception than a homeostatical-
ly-imposed refractory boundary at the level of sympathetic
outﬂow. This interpretation must, however, remain speculative,
as our results only pertain to pain-evoked potentials and we did
not speciﬁcally assess the activity of sympathetic nerves.
Our experimental paradigm did not evoke signiﬁcant peripheral
physiological (i.e. heart rate and blood pressure) change, either of
cue-related expectancy or nociceptive stimulation. This might be
related to the short inter-stimulus time (i.e., approximately 7 s)
or due to the fact that, in contrast with the previous work, here
participants were engaged in recognizing visual stimuli rather than
passively waiting for nociceptive stimulation [39]. Importantly, the
absence of peripheral physiological effects ensured that the ob-
served interaction was genuinely between neural aspects of the
expectancy state and cardiac timing, rather than directly explain-
able in terms of expectancy-related systematic physiological
changes.
Our cued pain paradigm also has similarities to paradigms seek-
ing to differentiate ‘‘fear” from ‘‘anxiety” inﬂuences on nociception
[57,61]. These studies suggest that probable but unpredictable pain
(un-cued pain in our experiment) activates ‘‘anxiety” circuitry
encouraging hypervigilant evaluation of external and somatic envi-
ronments [30], whereas directly cued imminent pain activates
‘‘fear” circuitry inducing ﬁght/ﬁght responses. Activating ‘‘anxiety
circuitry” increases pain sensitivity and hyperalgesia [57,67],
whereas activating ‘‘fear circuitry” decreases pain sensitivity via
cortico-limbic [36,40,52], midbrain [46,66] and spinal [2,47] anal-
gesic mechanisms. Our ﬁnding however, that P2 amplitude is in-
creased to directly cued pain is inconsistent with this literature,
and appears instead to be more directly related to attentional phe-
nomena [73].
A fundamental question pertains to the functional anatomical
substrates of the observed interaction. Source localization studies
and intracranial recordings have shown that pain-related evoked
potentials collectively originate from the pre- and post-central
gyri, the anterior cingulate cortex and the insula [6,32,33,65,69–
71]. While the pre- and post-central gyri receive nociceptive
stimuli only through the thalamus (lateral pathway), nociceptive
stimuli propagate to the anterior cingulate cortex, insula [43] and
amygdala also through the rostro-ventral medulla and the peri-
acqueductal gray matter (medial pathway;[74]). At its simplest,
the baroreﬂex is a vagal and brainstem-mediated reﬂex ensuring
beat-to-beat alterations in blood pressure remain within homoeo-
statically deﬁned boundaries [44]. However, baroreceptor afferent
information is also transmitted to regions including the insula,
which is also implicated in representating cardiovascular afferent
information [37–39,77]. We have previously demonstrated that
baroreceptor inﬂuences on cardiovascular pain reﬂexes are associ-
ated with activity within the periaqueductal gray matter (PAG),
amygdala and insula [39]. Functional imaging also reveals atten-
tion-related activity within regions including the amygdala, insula
and prefrontal cortex [9] may directly inﬂuence nociceptive pain
processing [56,73]. Further, the potential for lesions within PAG
[10], amygdala [40] and prefrontal cortex [52] to inﬂuence antino-
ciception implicates these regions as candidates mediating the
interaction between attention and cardiac afferents on nociception.
One can broadly hypothesize two complementary but not
mutually-exclusive mechanisms: (1) cortical and paralimbic
860 M.A. Gray et al. / PAIN

151 (2010) 853–861(cognitive-emotional) interactions with baroreceptor afferents in
the thalamus, brainstem or PAG and (2) an interaction within cor-
tical and paralimbic regions themselves, including the amygdala,
insula and cingulate cortex. Future brain imaging studies are nec-
essary to extend our ﬁndings and speciﬁcally delineate the neural
systems which mediate the observed interaction.
In summary, our study provides what is, to our knowledge, the
ﬁrst evidence that baroreceptor activity interacts with expectancy
induced by a visual warning cue. Namely, expectancy determines
the inﬂuence of baroreceptor activity on central signatures of noci-
ception. In parallel, baroreceptor discharge appears to interfere
with the effect of expectancy on nociceptive processing. The effects
of expectancy and visceral context on nociception therefore appear
closely integrated, suggesting that baroreceptor function may
interact with other aspects of cognitive-emotional function. Our
ﬁndings also contribute to understandings of anti-nociceptive
mechanisms, with relevance to the combined inﬂuence of mental
and physiological contributions to clinical pain.
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